Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Clinical trial NCT01875666 · COMPLETED
Trial details
- NCT number
- NCT01875666
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-05
- Primary completion
- 2016-12-19
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.